Publications
Effects of GSK v Teva Ripple after SCOTUS Denies Cert
Co-Author, Life Sciences IP Review
Chad Landmon, Hatch-Waxman & Biologics Chair, offers insight on the effects of GSK v Teva after SCOTUS ruling.
Firm Highlights
Slide 1 of 6
- PublicationElection Year Politics and Policy at CMMI: What Stakeholders Can ExpectCMS’ Innovation Center is accelerating new payment and care delivery models as the Trump administration uses CMMI to advance health policy priorities.Read more
- EventFrom Model to Practice: How Providers Are Successfully Implementing GUIDEJoin Polsinelli, Pocket RN and Right At Home for a practical discussion on participating in Medicare’s GUIDE (Guiding an Improved Dementia Experience) model.Read more
- Blog
The New Rules of Federal Contracting: Redefining DEI ComplianceRead more - NewsPolsinelli Secures Declaratory Relief in Board of Directors DisputePolsinelli recently prevailed in a lawsuit in the Delaware Court of Chancery for declaratory relief on behalf of Plaintiffs Christopher Ropko and Thomas Burdi against Defendant Phillip McNeill, Jr. (McNeill) under 6 Del. C. §§ 18-110 and 18-111.Read more
- NewsPolsinelli Represents Leisure Hydration on its Oversubscribed Series A FinancingPolsinelli congratulates its client Leisure Hydration, on its oversubscribed Series A Financing.Read more
- PublicationDesign Patents Expand for Digital Products While Courts Signal New Limits on EnforcementOn March 13, 2026, the USPTO issued supplemental guidance modernizing design patent eligibility for computer-generated designs.Read more